| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.074 | 0.1 |